Announcements Trials
Browse Landscape

Phase

Phase 2 12Phase 1 5Phase 3 3Phase EARLY_PHASE1 2Phase 2/3 2Phase NA 1Phase 1/2 1

Status

Completed 26Recruiting 8Terminated 7Withdrawn 5Unknown 2Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 2Sarcoma 1Head & Neck 1CNS 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Sarcoma 1Glioblastoma 1Esophageal Neoplasms 1Clinical Stage I Gastric Cancer AJCC v8 1

Interventions

Cyclophosphamide 35Cisplatin 24fludarabine 23Radiotherapy 23Paclitaxel 21Carboplatin 20pembrolizumab 18Nivolumab 18Magnetic Resonance Spectroscopy 18Specimen Handling 17fludarabine phosphate 15Gemcitabine 15Biopsy 15Cytarabine 14Radiation 11Filgrastim 11Doxorubicin 11Docetaxel 11Dexamethasone 11Radiosurgery 10Granulocyte Colony-Stimulating Factor 10Etoposide 10Melphalan 9Ipilimumab 9venetoclax 8Rituximab 8Calcium Dobesilate 8trametinib 7ibrutinib 7durvalumab 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 1 × Withdrawn × Surgical Procedures, Operative × Clear all
NCT06670976 2025-08-26

Propranolol Plus Standard Radiation Therapy Before Surgery for the Treatment of Patients With Soft Tissue Sarcoma

Roswell Park Cancer Institute

Phase 1 Withdrawn
Sarcoma

Sarcoma

NCT05296005 2025-02-07

Neoadjuvant Therapy for the Treatment of Gastroesophageal Junction and Gastric Cancers

Ohio State University Comprehensive Cancer Center

Phase 1 Withdrawn
Gastrointestinal

Clinical Stage I Gastric Cancer AJCC v8

NCT03575234 2019-08-28

Nivolumab & IRX-2 With Surgery for Resectable Stage III-IVA Oral Cavity Cancer or HPV-Positive Oropharyngeal Cancer

Emory University

Phase 1 Withdrawn
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT03480867 2019-08-14

PARADIGMA

McGill University Health Centre/Research Institute of the McGill University Health Centre

Phase 1 Withdrawn
CNS

Glioblastoma

NCT02598687 2016-04-21

Testing TH-302, in Combination With Preoperative Chemoradiotherapy, in Esophageal Cancer.

Maastricht Radiation Oncology

Phase 1 Withdrawn
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡